Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
AstraZeneca
Moodys
Farmers Insurance
Queensland Health
Cantor Fitzgerald
Baxter
Express Scripts
QuintilesIMS

Generated: October 20, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,207,215

« Back to Dashboard

Claims for Patent: 8,207,215

Title:Ketorolac tromethamine compositions for treating or preventing ocular pain
Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
Inventor(s): Muller; Christopher A. (Foothill Ranch, CA), Cheetham; Janet K. (Laguna Niguel, CA), Kuan; Teresa H. (Placentia, CA), Power; David F. (Trabuco Canyon, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:11/842,915
Patent Claims: 1. A method of controlling ocular postoperative inflammation or ocular postoperative pain comprising topically administering to said patient a composition comprising 0.4% w/v ketorolac tromethamine.

2. The method of claim 1 wherein said ocular postoperative pain is a result of photorefractive keratectomy surgery.

3. The method of claim 1 wherein said composition comprises 0.4% w/v ketorolac tromethamine, about 0.006% w/v benzalkonium chloride, about 0.015% w/v edetate disodium, about 0.003% w/v Octoxynol-40, and about 0.79% w/v sodium chloride.

4. The method of claim 3 wherein said composition comprises 0.4% w/v ketorolac tromethamine, 0.006% w/v benzalkonium chloride, 0.015% w/v edetate disodium, 0.003% w/v Octoxynol-40, 0.79% w/v sodium chloride, and an effective amount of sodium hydroxide and hydrochloric acid to adjust the pH to a range of 7.2 to 7.6.

5. The method of claim 1 wherein said composition consists of 0.4% w/v ketorolac tromethamine, 0.006% w/v benzalkonium chloride, 0.015% w/v edetate disodium, 0.003% w/v Octoxynol-40, 0.79% w/v sodium chloride, water and an effective amount of sodium hydroxide and hydrochloric acid to adjust the pH to a range of 7.2 to 7.6.

6. The method of claim 1 wherein said composition comprises 0.4% w/v ketorolac tromethamine, 0.006% w/v benzalkonium chloride, 0.015% w/v edetate disodium, 0.003% w/v Octoxynol-40, 0.79% w/v sodium chloride, and an effective amount of sodium hydroxide or hydrochloric acid to adjust the pH.

7. The method of claim 1 wherein said composition consists essentially of 0.4% w/v ketorolac tromethamine, 0.006% w/v benzalkonium chloride, 0.015% w/v edetate disodium, 0.003% w/v Octoxynol-40, 0.79% w/v sodium chloride, water and an effective amount of sodium hydroxide or hydrochloric acid to adjust the pH to a range of 7.2 to 7.6.

8. The method of claim 1 wherein said composition consists of 0.4% w/v ketorolac tromethamine, 0.006% w/v benzalkonium chloride, 0.015% w/v edetate disodium, 0.003% w/v Octoxynol-40, 0.79% w/v sodium chloride, water and an effective amount of sodium hydroxide or hydrochloric acid to adjust the pH.

9. The method of claim 1 wherein the method controls post-operative burning and stinging.

10. The method of claim 1 wherein the composition further comprises benzalkonium chloride.

11. The method of claim 1 wherein the composition further comprises about about 0.006% w/v benzalkonium chloride.

12. The method of claim 1 wherein the composition further comprises edetate disodium.

13. The method of claim 1 wherein the composition further comprises about 0.015% w/v edetate disodium.

14. The method of claim 1 wherein the composition further comprises Octoxynol-40.

15. The method of claim 1 wherein the composition further comprises about 0.003% w/v Octoxynol-40.

16. The method of claim 1 wherein the composition further comprises sodium chloride.

17. The method of claim 1 wherein the composition further comprises about 0.79% w/v sodium chloride.

18. The method of claim 1 wherein the composition has a pH of about 7.4.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
UBS
Teva
Argus Health
Federal Trade Commission
McKesson
Johnson and Johnson
Novartis
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot